Daly City, CA, United States of America

Ashkaan Younai

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 10.8

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • San Francisco, CA (US) (2019 - 2020)
  • Daly City, CA (US) (2020 - 2022)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Ashkaan Younai

Introduction

Ashkaan Younai is a prominent inventor based in Daly City, California. He has made significant contributions to the field of chemistry, particularly in the development of G protein-coupled receptor modulators. With a total of eight patents to his name, Younai's work has the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents is a method for making trans isomeric forms of G protein-coupled receptor modulators. This patent discloses methods for synthesizing a trans isomeric form of a C—C chemokine receptor type 4 (CCR4) modulator. The process involves reacting specific compounds in the presence of a carboxylic acid directed reducing agent, resulting in a predominantly trans isomerically pure compound. Another notable patent focuses on chemokine receptor modulators and their uses, detailing compounds and methods for modulating certain chemokine receptor activity.

Career Highlights

Throughout his career, Ashkaan Younai has worked with notable companies such as Rapt Therapeutics, Inc. and Flx Bio, Inc. His experience in these organizations has allowed him to further his research and development efforts in the pharmaceutical industry.

Collaborations

Younai has collaborated with esteemed colleagues, including Jeffrey J. Jackson and David Juergen Wustrow. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Ashkaan Younai's contributions to the field of chemistry and his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic options in the treatment of various conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…